Asker Healthcare Group ABCHIX:ASKERS 20 PB Ratio is 4.34 as of Jul. 04, 2026, which is 13% below its 10-year median of 5.01. GuruFocus rates CHIX:ASKERS with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 110 Medical Distribution companies, Asker Healthcare Group AB ranks worse than 90% on this metric.
Asker Healthcare Group AB stock PB Ratio (=4.12) is close to 2-year low of 3.73.
The historical rank and industry rank for Asker Healthcare Group AB's PB Ratio or its related term are showing as below:
CHIX:ASKERs'
s PB Ratio Range Over the Past 10 Years
Min: 3.73 Med: 5.01 Max: 9.05
Current: 4.12
During the past 4 years, Asker Healthcare Group AB's highest PB Ratio was 9.05. The lowest was 3.73. And the median was 5.01.
CHIX:ASKERs's PB Ratio is ranked worse than 90% of 110
companies
in the Medical Distribution industry
Industry Median: 1.02
vs CHIX:ASKERs: 4.12
During the past 12 months, Asker Healthcare Group AB's average Book Value Per Share Growth Rate was 10.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 33.40% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Asker Healthcare Group AB was 33.40% per year. The lowest was 33.40% per year. And the median was 33.40% per year.
Back to Basics: PB Ratio
Asker Healthcare Group AB (CHIX:ASKERs) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Asker Healthcare Group AB PB Ratio Related Terms
Asker Healthcare Group AB PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Asker Healthcare Group AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Asker Healthcare Group AB (CHIX:ASKERS) has a PB Ratio of 4.34 as of Jul. 04, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Asker Healthcare Group AB and its competitors. This is 13% below median its historical median of 5.01. Over the past decade, Asker Healthcare Group AB's PB Ratio has ranged from 3.73 to 9.05. According to the industry distribution chart, Asker Healthcare Group AB ranks #99 out of 110 companies in the Medical Distribution industry, placing it in the top 90%.
Is Asker Healthcare Group AB's PB Ratio too high?
Asker Healthcare Group AB's current PB Ratio of 4.34 is 13% below median its 10-year median of 5.01. Over the past 10 years, this metric has ranged from a low of 3.73 to a high of 9.05. The Medical Distribution industry median PB Ratio is 1.02. Asker Healthcare Group AB's value of 4.34 is 325.5% above this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #99 out of 110 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Asker Healthcare Group AB has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #99 out of 110 companies for PB Ratio. This places Asker Healthcare Group AB in the lower half of its industry. The industry median PB Ratio is 1.02. Asker Healthcare Group AB's value of 4.34 is 325.5% above this benchmark. Historically, Asker Healthcare Group AB's own PB Ratio has ranged from 3.73 to 9.05 over the past decade. While the company's 10-year median is 5.01 vs. the industry median of 1.02, Asker Healthcare Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.02, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current PB Ratio of 4.34 is 325.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current PB Ratio is 4.34, which is 13% below median its own 10-year median of 5.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (CHIX:ASKERS) has a current PB Ratio of 4.34. The current PB Ratio is 4.34, which is 13% below median its 10-year median of 5.01 and 325.5% above the Medical Distribution industry median of 1.02. Asker Healthcare Group AB's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Asker Healthcare Group AB (CHIX:ASKERS), the current PB Ratio is 4.34 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
20GF Score
Get the complete analysis for CHIX:ASKERS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ASKERS has been successfully added to your 
